Neurocrine Biosciences Inc $15.23

up +0.15


22/8/2014 02:22 PM  |  NASDAQ : NBIX  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get NBIX Trend Analysis - it has underperformed the S&P 500 by 15%

Partner Headlines

  1. US Stock Futures Tumble Ahead Of Durable-Goods Orders, Jobless Claims Data

    Benzinga
  2. Weekly Insider Sells Highlight: ORCL, TWC, FB, NBIX

    GuruFocus
  3. Benzinga's Top #PreMarket Losers

    Benzinga
  4. Mid-Afternoon Market Update: Markets Post Large Rally as Textron Falls ...

    Benzinga
  5. Mid-Morning Market Update: Markets Open Higher; IHS Profit Beats Estimates

    Benzinga
  6. Benzinga's Volume Movers

    Benzinga
  7. Morning Market Movers

    Benzinga
  8. Stock Futures Positive, Steady; Netflix Dives On Downgrade

    IBD
  9. Benzinga's Top #PreMarket Gainers

    Benzinga
  10. Neurocrine Announces Positive Results of VMAT2 Inhibitor NBI-98854 in Kinect ...

    Benzinga
  11. Kilroy Realty Acquires Premier Del Mar Office Campus for Approximately ...

    Benzinga
  12. Market Wrap For Tuesday, September 10: Once Again, China Moves Markets ...

    Benzinga
  13. Mid-Afternoon Market Update: Apple Releases Two New iPhones, SolarCity ...

    Benzinga
  14. Mid-Day Market Update: Five Below Shares Gain On Upbeat Results; Urban ...

    Benzinga
  15. Mid-Morning Market Update: Markets Rise; McDonald's Global Same-Store Sales ...

    Benzinga
  16. Morning Market Losers

    Benzinga
  17. Benzinga's Top Pre-Market Losers

    Benzinga
  18. UPDATE: Deutsche Bank Raises PT on Neurocrine Biosciences Ahead of Key ...

    Benzinga
  19. Neurocrine shares

    IBD
  20. Neurocrine Stock Jumps As Cowen Touts Dyskinesia Drug

    IBD
  21. UPDATE: Jefferies Reiterates Buy Rating, Raises PT on Neurocrine Biosciences ...

    Benzinga
  22. Stocks Hitting 52-Week Highs

    Benzinga
  23. Neurocrine Biosciences Inc. Reports Operating Results (10-K)

    GuruFocus
  24. Earnings Scheduled For February 8, 2013

    Benzinga
  25. Mid-Afternoon Market Update: Markets Edge Toward Record Highs, Arch Coal ...

    Benzinga
  26. Neurocrine Biosciences Inc. Reports Operating Results (10-Q)

    GuruFocus
  27. UPDATE: Morgan Stanley Initiates Neurocrine Biosciences at Overweight ...

    Benzinga
  28. Neurocrine Biosciences Announces Urocortin 2 Phase II Study Results in ...

    Benzinga
  29. Neurocrine Biosciences Inc. Reports Operating Results (10-K)

    GuruFocus
  30. Top 5 Small-Cap Drug Firms Include Questcor, Cubist

    IBD
  31. Neurocrine Biosciences

    IBD
  32. Neurocrine Biosciences Prices Public Offering of Common Stock at $8.10 ...

    Benzinga
Trading Center